Literature DB >> 23470638

Parkin deficiency contributes to pancreatic tumorigenesis by inducing spindle multipolarity and misorientation.

Xiaodong Sun1, Min Liu, Jihui Hao, Dengwen Li, Youguang Luo, Xiuchao Wang, Yunfan Yang, Fang Li, Wenqing Shui, Quan Chen, Jun Zhou.   

Abstract

Parkin, an E3 ubiquitin ligase well known for its role in the pathogenesis of juvenile Parkinson disease, has been considered as a candidate tumor suppressor in certain types of cancer. It remains unknown whether parkin is involved in the development of pancreatic cancer, the fourth leading cause of cancer-related deaths worldwide. Herein, we demonstrate the downregulation and copy number loss of the parkin gene in human pancreatic cancer specimens. The expression of parkin negatively correlates with clinicopathological parameters indicating the malignancy of pancreatic cancer. In addition, knockdown of parkin expression promotes the proliferation and tumorigenic properties of pancreatic cancer cells both in vitro and in mice. We further find that parkin deficiency increases the proportion of cells with spindle multipolarity and multinucleation. Parkin-depleted cells also show a significant increase in spindle misorientation. These findings indicate crucial involvement of parkin deficiency in the pathogenesis of pancreatic cancer.

Entities:  

Keywords:  cell proliferation; pancreatic cancer; parkin; spindle misorientation; spindle multipolarity

Mesh:

Substances:

Year:  2013        PMID: 23470638      PMCID: PMC3646869          DOI: 10.4161/cc.24215

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  45 in total

Review 1.  Centrosomal amplification and spindle multipolarity in cancer cells.

Authors:  William Saunders
Journal:  Semin Cancer Biol       Date:  2005-02       Impact factor: 15.707

2.  The bipolar mitotic kinesin Eg5 moves on both microtubules that it crosslinks.

Authors:  Lukas C Kapitein; Erwin J G Peterman; Benjamin H Kwok; Jeffrey H Kim; Tarun M Kapoor; Christoph F Schmidt
Journal:  Nature       Date:  2005-05-05       Impact factor: 49.962

Review 3.  Biology and management of pancreatic cancer.

Authors:  Paula Ghaneh; Eithne Costello; John P Neoptolemos
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

4.  Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer.

Authors:  A Letessier; S Garrido-Urbani; C Ginestier; G Fournier; B Esterni; F Monville; J Adélaïde; J Geneix; L Xerri; P Dubreuil; P Viens; E Charafe-Jauffret; J Jacquemier; D Birnbaum; M Lopez; M Chaffanet
Journal:  Oncogene       Date:  2006-07-03       Impact factor: 9.867

5.  Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.

Authors:  Xabier Agirre; José Román-Gómez; Iria Vázquez; Antonio Jiménez-Velasco; Leire Garate; Cristina Montiel-Duarte; Paula Artieda; Lucia Cordeu; Idoya Lahortiga; María José Calasanz; Anabel Heiniger; Antonio Torres; John D Minna; Felipe Prósper
Journal:  Int J Cancer       Date:  2006-04-15       Impact factor: 7.396

Review 6.  Genetics and biology of pancreatic ductal adenocarcinoma.

Authors:  Aram F Hezel; Alec C Kimmelman; Ben Z Stanger; Nabeel Bardeesy; Ronald A Depinho
Journal:  Genes Dev       Date:  2006-05-15       Impact factor: 11.361

7.  Parkin enhances mitochondrial biogenesis in proliferating cells.

Authors:  Yukiko Kuroda; Takao Mitsui; Makoto Kunishige; Masayuki Shono; Masashi Akaike; Hiroyuki Azuma; Toshio Matsumoto
Journal:  Hum Mol Genet       Date:  2006-01-31       Impact factor: 6.150

Review 8.  Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer.

Authors:  K S Goonetilleke; A K Siriwardena
Journal:  Eur J Surg Oncol       Date:  2006-11-09       Impact factor: 4.424

Review 9.  Ubiquitin, proteasome and parkin.

Authors:  Keiji Tanaka; Toshiaki Suzuki; Nobutaka Hattori; Yoshikuni Mizuno
Journal:  Biochim Biophys Acta       Date:  2004-11-29

10.  Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels.

Authors:  Monica Joch; Ariel R Ase; Carol X-Q Chen; Penny A MacDonald; Maria Kontogiannea; Amadou T Corera; Alexis Brice; Philippe Séguéla; Edward A Fon
Journal:  Mol Biol Cell       Date:  2007-06-06       Impact factor: 4.138

View more
  25 in total

1.  Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.

Authors:  De-Chen Lin; Liang Xu; Ye Chen; Haiyan Yan; Masaharu Hazawa; Ngan Doan; Jonathan W Said; Ling-Wen Ding; Li-Zhen Liu; Henry Yang; Shizhu Yu; Michael Kahn; Dong Yin; H Phillip Koeffler
Journal:  Cancer Res       Date:  2015-04-15       Impact factor: 12.701

Review 2.  Mitophagy mechanisms and role in human diseases.

Authors:  Matthew Redmann; Matthew Dodson; Michaël Boyer-Guittaut; Victor Darley-Usmar; Jianhua Zhang
Journal:  Int J Biochem Cell Biol       Date:  2014-05-16       Impact factor: 5.085

3.  Parkin New Cargos: a New ROS Independent Role for Parkin in Regulating Cell Division.

Authors:  David C Stieg; Katrina F Cooper
Journal:  React Oxyg Species (Apex)       Date:  2016

4.  Implication of alterations in Parkin gene among North Indian patients with colorectal cancer.

Authors:  Raj Ranjan Tiwari; Khushnuma Wahabi; Ahmad Perwez; Zafar Iqbal Bhat; Syed Shamimul Hasan; Sundeep Singh Saluja; Moshahid Alam Rizvi
Journal:  Turk J Gastroenterol       Date:  2020-03       Impact factor: 1.852

5.  E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis.

Authors:  Valentina Montagnani; Luisa Maresca; Alessandro Apollo; Sara Pepe; Ryan M Carr; Martin E Fernandez-Zapico; Barbara Stecca
Journal:  J Biol Chem       Date:  2020-09-16       Impact factor: 5.157

6.  CYLD regulates spindle orientation by stabilizing astral microtubules and promoting dishevelled-NuMA-dynein/dynactin complex formation.

Authors:  Yunfan Yang; Min Liu; Dengwen Li; Jie Ran; Jinmin Gao; Shaojun Suo; Shao-Cong Sun; Jun Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

Review 7.  An emerging role of PARK2 in cancer.

Authors:  Liang Xu; De-chen Lin; Dong Yin; H Phillip Koeffler
Journal:  J Mol Med (Berl)       Date:  2013-12-03       Impact factor: 4.599

Review 8.  Mitochondrial control of cell bioenergetics in Parkinson's disease.

Authors:  Raquel Requejo-Aguilar; Juan P Bolaños
Journal:  Free Radic Biol Med       Date:  2016-04-16       Impact factor: 7.376

Review 9.  Parkin in Parkinson's Disease and Cancer: a Double-Edged Sword.

Authors:  Khushnuma Wahabi; Ahmad Perwez; Moshahid A Rizvi
Journal:  Mol Neurobiol       Date:  2018-01-18       Impact factor: 5.590

10.  Parkin protein expression and its impact on survival of patients with advanced colorectal cancer.

Authors:  Claudia Caroline Veloso da Silva-Camargo; Rosimeri Kuhl Svoboda Baldin; Nayanne Louise Costacurta Polli; Amanda Pereira Agostinho; Marcia Olandosk; Lúcia de Noronha; Vanessa Santos Sotomaior
Journal:  Cancer Biol Med       Date:  2018-02       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.